Investing in Disruptive Tech: Capturing the Growth of Robotics, AI & Health Tech
For those interested in investing in disruptive technologies, the path can be both rewarding and complex. Capturing the growth of robotics, AI, and healthcare tech requires in-depth research paired with a diversified approach. In this webinar, you’ll learn about the companies at the forefront of this technology revolution and how to gain exposure with three unique, global portfolios.
Join ROBO Global for a discussion on the best ways for investors to capitalize on the robotics, AI, and healthcare tech revolution.
Key takeaways include:
- Why smart investors should incorporate disruptive technologies in their portfolios to prepare for the future.
- A concrete understanding of the ROBO Global innovation indices: HTEC, THNQ, and ROBO.
- How the pandemic has paved a path to increased investment and innovation in healthcare.
Markit Manufacturing Continues Improvement in November
The November US Manufacturing Purchasing Managers' Index conducted by Markit came in at 56.7, up 1.8 from the 53.4 final October figure. Markit's Manufacturing PMI is a diffusion index: A reading above 50 indicates expansion in the sector; below 50 indicates contraction.
The Big Four: Real Personal Income in October
Personal Income (excluding Transfer Receipts) in October rose 0.78% and is up 2.2% year-over-year. However, when adjusted for inflation using the BEA's PCE Price Index, Real Personal Income (excluding Transfer Receipts) MoM was up 0.78%. The real number is up 1.0% year-over-year.
Distressed Credit Opportunities on Rise Amid Uncertainties in Middle Markets
Liquidity issues and other business risks could prompt a wave of defaults and restructurings, in turn creating fertile ground for opportunistic investing in distressed credit.
Vaccine Hopes Shouldn’t Drive Healthcare Investing Strategies
Healthcare stocks are once again in focus as a result of promising news of COVID-19 vaccines. But investors shouldn’t hunt for the pandemic’s panacea. Focusing on business fundamentals is a much better way to find healthcare stocks with long-term potential than searching for the next big drug.
Will growth investors have the nerve to be contrarians?
In RBA’s latest report, Rich revisits the "Earnings Expectations Life Cycle" from the perspective of growth versus value investors and outlines why growth investors need to be contrarians in 2021.
Lockdowns Test the Economic Endurance of Desperate Americans
American workers and businesses face a months-long survival test until Covid-19 vaccines become widely available as spending plunges with record daily cases prompting a sudden return to lockdowns.